Nutra Pharma has announced that it will be presenting and exhibiting at the upcoming MoneyShow in Las Vegas, Nevada, from May 10 to May 13, 2010.
Nutra Pharma Corp., a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it will be presenting and exhibiting at the upcoming MoneyShow in Las Vegas, Nevada.
“The Las Vegas MoneyShow is considered one of the largest investor conferences in the United States,” explained Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. “We believe this conference will provide an excellent opportunity to continue building awareness about Nutra Pharma and our drug pipeline, including our pain relievers, Cobroxin and Nyloxin,” he added.
The MoneyShow, which is scheduled for May 10th through May 13th, will be held at Caesars Palace in Las Vegas, Nevada. For additional information, visit: http://www.moneyshow.com/lvms/.
This press release contains forward-looking statements. The words or phrases "would be," "will allow," "intends to," "will likely result," "are expected to," "will continue," "is anticipated," "estimate," "project," or similar expressions are intended to identify "forward-looking statements." Actual results could differ materially from those projected in Nutra Pharma's ("the Company") business plan. The Company's business is subject to various risks, which are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"). The above statements pertaining to the MoneyShow in Las Vegas, Nevada should not be construed as an indication in any way whatsoever of: (a) the Company’s financial value; and/or (b) any predictive value of the Company’s future stock price. The Company's filings may be accessed at the SEC's Edgar system at www.sec.gov. Statements made herein are as of the date of this press release and should not be relied upon as of any subsequent date. The Company cautions readers not to place reliance on such statements. Unless otherwise required by applicable law, we do not undertake, and we specifically disclaim any obligation, to update any forward-looking statements to reflect occurrences, developments, unanticipated events or circumstances after the date of such statement.